On September 29, 2023, the first batch of formulated products from Zencore Biologics' ADC formulation workshop completed the freeze-drying process. This signifies the complete integration of Zencore Biologics' ADC business division, spanning from research and development to commercial production. With this achievement, Zencore Biologics has officially established a "One-Stop" service platform for antibody to ADC research and production. This platform will enable us to better provide our global business partners with high-quality and cost-effective services.
